Endogenous 5-hydroxytryptamine modulates the release of tachykinins and calcitonin gene-related peptide from the rat spinal cord via 5-HT3 receptors.
Saria
A
A
Department of Psychiatry, University of Innsbruck Medical School, Austria.
Javorsky
F
F
Humpel
C
C
Gamse
R
R
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism*; D017829:Granisetron; D066298:In Vitro Techniques; D007191:Indazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D015288:Neurokinin A / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology*; D012701:Serotonin / Q000494:pharmacology / Q000502:physiology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013116:Spinal Cord / Q000187:drug effects / Q000502:physiology*; D013373:Substance P / Q000378:metabolism; D015320:Tachykinins / Q000378:metabolism*; D000077526:Tropisetron
D015740:Calcitonin Gene-Related Peptide; D017829:Granisetron; D007191:Indazoles; D007211:Indoles; D015288:Neurokinin A; D011189:Potassium Chloride; D011985:Receptors, Serotonin; D012701:Serotonin; D012702:Serotonin Antagonists; D013373:Substance P; D015320:Tachykinins; D000077526:Tropisetron